Abstract
BackgroundPlasmodium parasites are unable to synthesize purines de novo and have to salvage them from the host. Due to this limitation in the parasite, purine transporters have been an area of focus in the search for anti-malarial drugs. Although the uptake of purines through the human equilibrative nucleoside transporter (hENT1), the human facilitative nucleobase transporter (hFNT1) and the parasite-induced new permeation pathway (NPP) has been studied, no information appears to exist on the relative contribution of these three transporters to the uptake of adenosine and hypoxanthine. Using the appropriate transporter inhibitors, the role of each of these salvage pathways to the overall purine transport in intraerythrocytic Plasmodium falciparum was systematically investigated.MethodsThe transport of adenosine, hypoxanthine and adenine into uninfected and P. falciparum-infected human erythrocytes was investigated in the presence or absence of classical inhibitors of the hFNT1, hENT1 and NPP. The effective inhibition of the various transporters by the classical inhibitors was verified using appropriate known substrates. The ability of high concentration of unlabelled substrates to saturate these transporters was also studied.ResultsTransport of exogenous purine into infected or uninfected erythrocytes occurred primarily through saturable transporters rather than through the NPP. Hypoxanthine and adenine appeared to enter erythrocytes mainly through the hFNT1 nucleobase transporter whereas adenosine entered predominantly through the hENT1 nucleoside transporter. The rate of purine uptake was approximately doubled in infected cells compared to uninfected erythrocytes. In addition, it was found that the rate of adenosine uptake was considerably higher than the rate of hypoxanthine uptake in infected human red blood cells (RBC). It was also demonstrated that furosemide inhibited the transport of purine bases through hFNT1.ConclusionCollectively, the data obtained in this study clearly show that the endogenous host erythrocyte transporters hENT1 and hFNT1, rather than the NPP, are the major route of entry of purine into parasitized RBC. Inhibitors of hENT1 and hFNT1, as well as the NPP, should be considered in the development of anti-malarials targeted to purine transport.
Highlights
Plasmodium parasites are unable to synthesize purines de novo and have to salvage them from the host
The Km and Vmax values were obtained for the transporters using the Michaelis-Menten plot. Classical inhibitors such as the nitro-2-(3-phenylpropylamino) benzoic acid (NPPB), NBMPR and furosemide were chosen for use in this study based on their published properties and subsequent verification in preliminary experiments in this study
We tested the effect of NPPB on the uptake of sorbitol, a well-known substrate of the new permeation pathway (NPP) [11,23], into infected red blood cells (RBC)
Summary
Plasmodium parasites are unable to synthesize purines de novo and have to salvage them from the host. While NBMPR completely blocks adenosine uptake in human erythrocytes, infection with P. falciparum induced an additional, NBMPR-insensitive, uptake mechanism in these cells [2,8] and this mechanism does not distinguish between the d and l-enantiomers of adenosine [9]. These observations helped define the concept of the new permeation pathway (NPP), an apparently nonsaturable channel-like system that transports low molecular weight compounds including purines, and is formed after parasite invasion of erythrocytes [10]. Using the patch-clamp technique, two groups confirmed the presence and properties of the NPP in P. falciparum-infected erythrocytes [14,15]
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have